chr9-96298451-C-T
Variant names: 
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000197.2(HSD17B3):c.166G>A(p.Ala56Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000479 in 1,461,340 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
 Genomes: not found (cov: 32) 
 Exomes 𝑓:  0.0000048   (  0   hom.  ) 
Consequence
 HSD17B3
NM_000197.2 missense
NM_000197.2 missense
Scores
 10
 8
 1
Clinical Significance
Conservation
 PhyloP100:  3.93  
Publications
4 publications found 
Genes affected
 HSD17B3  (HGNC:5212):  (hydroxysteroid 17-beta dehydrogenase 3) This isoform of 17 beta-hydroxysteroid dehydrogenase is expressed predominantly in the testis and catalyzes the conversion of androstenedione to testosterone.  It preferentially uses NADP as cofactor.  Deficiency can result in male pseudohermaphroditism with gynecomastia. [provided by RefSeq, Jul 2008] 
HSD17B3 Gene-Disease associations (from GenCC):
- 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
PP3
MetaRNN computational evidence supports a deleterious effect, 0.983
PP5
Variant 9-96298451-C-T is Pathogenic according to our data. Variant chr9-96298451-C-T is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 4879.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| HSD17B3 | ENST00000375263.8  | c.166G>A | p.Ala56Thr | missense_variant | Exon 2 of 11 | 1 | NM_000197.2 | ENSP00000364412.3 | ||
| ENSG00000285269 | ENST00000643789.1  | n.*1842G>A | non_coding_transcript_exon_variant | Exon 13 of 22 | ENSP00000494818.1 | |||||
| ENSG00000285269 | ENST00000643789.1  | n.*1842G>A | 3_prime_UTR_variant | Exon 13 of 22 | ENSP00000494818.1 | 
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD3 genomes 
Cov.: 
32
GnomAD2 exomes  AF:  0.00000796  AC: 2AN: 251394 AF XY:  0.0000147   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
2
AN: 
251394
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000479  AC: 7AN: 1461340Hom.:  0  Cov.: 30 AF XY:  0.00000413  AC XY: 3AN XY: 727044 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
7
AN: 
1461340
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
3
AN XY: 
727044
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33472
American (AMR) 
 AF: 
AC: 
0
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26132
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39694
South Asian (SAS) 
 AF: 
AC: 
7
AN: 
86254
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53408
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111514
Other (OTH) 
 AF: 
AC: 
0
AN: 
60374
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.468 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  Cov.: 32 
GnomAD4 genome 
Cov.: 
32
Alfa 
 AF: 
Hom.: 
ExAC 
 AF: 
AC: 
2
ClinVar
Significance: Likely pathogenic 
Submissions summary: Pathogenic:2 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Testosterone 17-beta-dehydrogenase deficiency    Pathogenic:2 
Nov 20, 2023
Clinical Biochemistry Laboratory, Health Services Laboratory
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ACMG:PM1 PM2 PP1 PP2 PP3 PP4 PP5 -
Aug 01, 1998
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Uncertain 
 BayesDel_addAF 
 Pathogenic 
D 
 BayesDel_noAF 
 Pathogenic 
 DANN 
 Pathogenic 
 DEOGEN2 
 Uncertain 
D;.;.;T 
 Eigen 
 Pathogenic 
 Eigen_PC 
 Pathogenic 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Uncertain 
D;D;D;D 
 M_CAP 
 Pathogenic 
D 
 MetaRNN 
 Pathogenic 
D;D;D;D 
 MetaSVM 
 Pathogenic 
D 
 MutationAssessor 
 Pathogenic 
M;M;.;. 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Uncertain 
D;D;.;. 
 REVEL 
 Pathogenic 
 Sift 
 Uncertain 
D;D;.;. 
 Sift4G 
 Uncertain 
D;D;.;. 
 Polyphen 
D;.;.;. 
 Vest4 
 MutPred 
Gain of phosphorylation at A56 (P = 0.082);Gain of phosphorylation at A56 (P = 0.082);Gain of phosphorylation at A56 (P = 0.082);Gain of phosphorylation at A56 (P = 0.082);
 MVP 
 MPC 
 ClinPred 
D 
 GERP RS 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 Splicevardb 
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.